NIH Starts Trial Looking at Rare Allergic Reactions to COVID Vaccines

THURSDAY, April 8, 2021 — A new clinical trial will investigate whether people who are highly allergic or have what’s known as a mast cell disorder are at higher risk for a sudden allergic reaction to the Moderna or Pfizer COVID-19 vaccines.
Source: Topamax